Sputum interleukin-17 is increased and associated with airway neutrophilia in patients with severe asthma

Chinese Medical Journal

Volumn 118, Issue 11, 2005, Pages 953-956

  Sun, Yong Chang ^a   Zhou, Qing Tao ^b   Yao, Wan Zhen ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Airway inflammation; Asthma; Interleukin 17

Indexed keywords

BUDESONIDE; CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; INTERLEUKIN 17; INTERLEUKIN 8; MYELOPEROXIDASE; STEROID;

ADULT; AIRWAY; ARTICLE; ASTHMA; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATORY CELL; MALE; NEUTROPHILIA; SPUTUM ANALYSIS;

ADULT; ASTHMA; BUDESONIDE; CELL DIFFERENTIATION; EOSINOPHIL CATIONIC PROTEIN; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-8; MALE; MIDDLE AGED; NEUTROPHILS; PEROXIDASE; PROSPECTIVE STUDIES; SPUTUM;

EID: 20944441664     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Global Initiative for Asthma(GINA). Global strategy for asthma management and prevention: NHLBI/WHO Workshop report. Bethesda, MD: National Heart, Lung and Blood Institute, National Institutes of Health. 2002.
2. Sun YC, Chu HW. Do neutrophils actively participate in airway inflammation and remodeling in asthma? Chin Med J 2004;117:1731-1742.
3. Cundall M, Sun Y, Miranda C, et al. Neutrophil - derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. J Allergy Clin Immunol 2003;112:1064-1071.
4. Wenzel SE, Szefler SJ, Leung DY, et al. Bronchoscopic evaluation of severe asthma: Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997;156:737-743.
5. Jatakanon A, Uasuf C, Maziak W, et al. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999;160:1532-1539.
6. Ordonez QL, Shaughnessy TE, Matthay MA, et al. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma. Clinical and biologic significance. Am J Respir Crit Care Med 2000; 161; 1185-1190.
7. Norzila MZ, Fakes K, Henry RL, et al. Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma. Am J Respir Crit Care Med 2000; 161: 769-774.
8. Laan M, Cui ZH, Hoshino H, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999; 162: 2347-2352.
9. Linden A, Hoshino H, Laan M. Airway neutrophils and interleukin-17. Eur Respir J 2000;15:973-977.
10. Pavord ID, Pizzicbini MM, Pizzicbini E, et al. The use of induced sputum to investigate airway inflammation. Thorax 1997;52:498-501.
11. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001;119:1329-1336.
12. European Network for Understanding Mechanisms of Severe Asthma. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 2003;22:470-477.
13. Green RH, Brightling CE, Woltmann G, et al. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002;57: 875-879.
14. Barczyk A, Pierzchala W, Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 2003;97:726-733.
15. Chakir J, Shannon J, Molet S, et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 2003;111:1293-1298.
16. Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001;108:430-438.
17. Barczyk A, Sozanska E, Trzaska M, et al. Decreased levels of myeloperoxidase in induced sputum of patients with COPD after treatment with oral glucocorticoids. Chest 2004;126:389-393.